CSE/VEXT (CSE/VEXT)

Canadian Securities Exchange: CSE/VEXT · CAD

CA$0.23

-0.01 (-2.1%)· Recorded snapshot

Market cap	57M
Revenue (ttm)	72M
Net income (ttm)	-20.4M
EPS (ttm)	-CA$0.08
Shares out	247.7M
P/E (forward)	33.6x
Volume	8,500
Beta	0.89

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 72M
Net income (ttm): -20.4M
EPS (ttm): -CA$0.08
P/E (forward): 33.6x
Market cap: 57M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E33.6

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-23

P25 n/aP50 n/aP75 n/a

ROIC-4.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CSE/VEXT indicators

Market & fundamental data

Available fields

202

Groups with data

Currency

USD

Showing 202 of 202 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-20
Enterprise value	CAD 98.5M
Exchange	Canadian Securities Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2015
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA9255401064
Last earnings date	2026-08-20
Last refreshed	2026-10-28
Market cap	CAD 57M
Next earnings date	2026-11-20
Price	CAD 0.23
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	cse/VEXT
Website	https://vextscience.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-35.87%
EV/EBITDA	5.9x
EV/FCF	20.45x
EV/Sales	1.39x
FCF / EV yield	4.89%
FCF yield	8.38%
Forward P/E	33.57x
Industry forward P/E	34.53x
P/(FCF - SBC) ratio	11.99x
P/(OCF - SBC) ratio	5.66x
P/B ratio	0.76x
P/FCF ratio	11.94x
P/OCF ratio	5.65x
P/S ratio	0.81x
Price/EBITDA ratio	3.76x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-7.2%
EBITDA margin	21.53%
FCF margin	6.85%
Gross margin	38.95%
Operating margin	-7.2%
Pretax margin	-24.92%
Profit margin	-28.39%
ROA	-1.82%
ROA (5Y)	0.2%
ROCE	-4.09%
ROE	-22.98%
ROE (5Y)	-4.46%
ROIC	-4.39%
ROIC (5Y)	-0.49%
SBC / revenue	0.03%
Tax / revenue	3.47%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	1
FCF growth	-60.3%
FCF growth 3Y	128.7%
Gross profit growth	49.07%
Gross profit growth (Q)	37.73%
Gross profit growth 3Y	6.7%
Gross profit growth 5Y	5.66%
Net income growth quarters	2
Net income growth years	1
OCF growth	-34.25%
OCF growth (Q)	-71.69%
OCF growth (QoQ)	-26.81%
OCF growth 3Y	12%
OCF growth 5Y	-2.05%
Revenue growth	14.8%
Revenue growth (Q)	-9.58%
Revenue growth (QoQ)	-0.3%
Revenue growth 3Y	14.06%
Revenue growth 5Y	9.03%
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -5.4M
Depreciation and amortization	CAD 20.4M
EBIT	CAD -5.2M
EBITDA	CAD 15.5M
EPS	CAD -0.08
FCF per share	CAD 0.02
Financing cash flow	CAD -5M
Free cash flow	CAD 4.9M
Free cash flow minus SBC	CAD 4.9M
Gross profit	CAD 28M
Income taxes	CAD 2.5M
Investing cash flow	CAD -5.3M
Net borrowing	CAD -4.7M
Net cash flow	CAD -22,722
Net income	CAD -20.4M
Operating cash flow minus SBC	CAD 10.3M
Operating income	CAD -5.2M
Revenue	CAD 72M
Stock-based compensation	CAD 19,881

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.7
Book value per share	CAD 0.31
Debt / EBITDA	2.84
Debt / equity	0.62
Debt / FCF	9.83
Goodwill	CAD 2.9M
Interest coverage	-0.84
Long-term assets	CAD 128.4M
Long-term liabilities	CAD 50.2M
Net cash (debt)	CAD -41.5M
Net cash / market cap	-71.32%
Net debt / EBITDA	2.68
Net debt / equity	0.54
Net debt / FCF	8.51
Piotroski F-Score	6
Property, plant and equipment	CAD 40.5M
Shareholders' equity	CAD 76.9M
Tangible book value	CAD -10.1M
Tangible book value per share	CAD -0.04
Total assets	CAD 166.4M
Total cash	CAD 6.4M
Total debt	CAD 48M
Total liabilities	CAD 89.4M
WACC	9.63%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.41
Current assets	CAD 38M
Current liabilities	CAD 39.3M
Current ratio	0.97
Inventory turnover	3.53
Net working capital	CAD 4M
Quick ratio	0.19
Working capital	CAD -1.3M
Working capital turnover	-68.71

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.26%
Shareholder yield	-0.26%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.26
1D price change	-2.13%
1M price change	-6%
1M total return	-6%
1W price change	-7.84%
1W total return	-7.84%
1Y price change	-12.96%
1Y return CAGR	-12.97%
1Y total return	-12.96%
20-day SMA	CAD 0.24
200-day SMA	CAD 0.26
3M price change	-4.08%
3M total return	-4.08%
3Y price change	-18.97%
3Y return CAGR	-6.77%
3Y total return	-18.97%
50-day SMA	CAD 0.26
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.40
52-week high date	2026-04-30
52-week low	CAD 0.19
52-week low date	2025-12-11
5Y price change	-69.48%
5Y return CAGR	-21.13%
5Y total return	-69.48%
6M price change	-16.07%
6M total return	-16.07%
All-time high	CAD 2.10
All-time high date	2019-05-21
All-time low	CAD 0.10
All-time low date	2025-05-12
Average true range (ATR)	CAD 0.01
Average volume	35.5K
Beta (1Y)	0.67
Beta (2Y)	0.52
Beta (5Y)	0.89
Change from 52-week high	-42.5%
Change from 52-week low	21.05%
Change from all-time high	-88.81%
Change from all-time low	135%
Change from open	-2.13%
Day's gap	0%
Dollar volume	CAD 1,955
High price	CAD 0.24
Low price	CAD 0.23
Monthly RSI	47.56
Open price	CAD 0.24
Position in 52-week range	0%
Previous close	CAD 0.24
Price vs 150-day SMA	-9.89%
Price vs 20-day SMA	-2.41%
Price vs 200-day SMA	-10.48%
Price vs 50-day SMA	-8.27%
Relative volume	0.24
RSI	44.38
Sharpe ratio	-0.23
Sharpe ratio (3Y)	0.37
Sharpe ratio (5Y)	0.05
Sortino ratio	-0.26
Sortino ratio (3Y)	0.65
Sortino ratio (5Y)	0.15
Volume	8.5K
Weekly RSI	45.48
YTD price change	-7.84%
YTD total return	-7.84%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	101.7M
Shares change (QoQ)	0%
Shares change (YoY)	0.26%
Shares held by insiders	22.39%
Shares held by institutions	35.44%
Shares outstanding	247.7M

Deeper analysis on CSE/VEXT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/VEXT report

Is a complete CSE/VEXT research report available?

No complete published report is available for cse/VEXT (CSE/VEXT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/VEXT (CSE/VEXT)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/VEXT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/VEXT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/VEXT

Frequently asked questions